The "Microbiome Collaboration and Licensing Deals 2016-2025" has been added to ResearchAndMarkets.com's offering.
This report contains a comprehensive listing of 245 microbiome deals announced since 2016, including financial terms where available and links to online deal records of actual microbiome partnering deals as disclosed by the deal parties. Additionally, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.
Microbiome Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the microbiome deals entered into by the world's leading biopharma companies. Fully revised and updated, the report provides details of microbiome deals from 2016 to 2025. The report provides a detailed understanding and analysis of how and why companies enter microbiome deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. The report includes collaboration, development, research and licensing deals.
The initial chapters of this report provide an orientation of microbiome dealmaking. Chapter 1 introduces the report; Chapter 2 overviews the trends in microbiome dealmaking since 2016; Chapter 3 highlights the leading microbiome deals since 2016, listed by headline value. Chapter 4 lists the top 25 most active companies in microbiome dealmaking, accompanied by a detailed listing of microbiome deals and publicly available contract documents. Chapters 5 and 6 comprehensively review microbiome deals and partnering agreements signed and announced since January 2016, organized by specific microbiome technology types.
Microbiome Collaboration and Licensing Deals provides the reader with the following key benefits:
- Understand deal trends since 2016
- Browse microbiome collaboration and licensing deals
- Benchmark analysis - identify market value of transactions
- Financials terms - upfront, milestone, royalties
- Directory of deals by company A-Z, deal type and therapy area
- Leading deals by value
- Most active dealmakers
- Identify assets and deal terms for each transaction
- Access contract documents - insights into deal structures
- Due diligence - assess suitability of your proposed deal terms for partner companies
- Save hundreds of hours of research time
Analyzing contract agreements allows due diligence of:
- What are the precise rights granted or optioned?
- What is actually granted by the agreement to the partner company?
- What exclusivity is granted?
- What is the payment structure for the deal?
- How are sales and payments audited?
- What is the deal term?
- How are the key terms of the agreement defined?
- How are IPRs handled and owned?
- Who is responsible for commercialization?
- Who is responsible for development, supply, and manufacture?
- How is confidentiality and publication managed?
- How are disputes to be resolved?
- Under what conditions can the deal be terminated?
- What happens when there is a change of ownership?
- What sublicensing and subcontracting provisions have been agreed?
- Which boilerplate clauses does the company insist upon?
- Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
- Which jurisdiction does the company insist upon for agreement law?
Key Topics Covered:
Executive Summary
Chapter 1 - Introduction
Chapter 2 - Trends in microbiome dealmaking
2.1. Introduction
2.2. Microbiome deals over the years
2.3. Most active microbiome dealmakers
2.4. Microbiome deals by deal type
2.5. Microbiome deals by therapy area
2.6. Microbiome deals by industry sector
2.7. Deal terms for microbiome deals
2.7.1 Microbiome deals headline values
2.7.2 Microbiome deal upfront payments
2.7.3 Microbiome deal milestone payments
2.7.4 Microbiome royalty rates
Chapter 3 - Leading microbiome deals
3.1. Introduction
3.2. Top microbiome deals by value
Chapter 4 - Most active microbiome dealmakers
4.1. Introduction
4.2. Most active microbiome dealmakers
4.3. Most active microbiome deals company profiles
Chapter 5 - Microbiome contracts dealmaking directory
5.1. Introduction
5.2. Microbiome contracts dealmaking directory
Chapter 6 - Microbiome dealmaking by technology type
For more information about this report visit https://www.researchandmarkets.com/r/fzbaqo
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250624114134/en/
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
